SCHEMBL9656740

SCHEMBL9656740

CCOc1ccc2c(O)c(OC)cc(O)c2c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 5/20 0.48
▸ HSD17B10 Q99714 4/20 0.48
▸ ALDH1A1 P00352 3/20 0.48
▸ ERN1 O75460 2/20 0.47
▸ HIF1A Q16665 2/20 0.44
▸ EPAS1 Q99814 1/20 0.44
▸ KDM4E B2RXH2 3/20 0.43
▸ ALOX15 P16050 2/20 0.43
▸ LMNA P02545 3/20 0.42
▸ ATM Q13315 1/20 0.41
▸ MEN1 O00255 4/20 0.41
▸ KMT2A Q03164 4/20 0.41
▸ ALOX12 P18054 3/20 0.41
▸ DPP4 P27487 2/20 0.41
▸ HPGD P15428 2/20 0.41
▸ NPC1 O15118 1/20 0.41
▸ TSHR P16473 1/20 0.40
▸ TUBB4A P04350 2/20 0.40
▸ TUBB P07437 2/20 0.40
▸ TUBA3C P0DPH7 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9657079 0.85 HIF1A (0.50) MAPTHSD17B10ALDH1A1ERN1HIF1A
SCHEMBL2022420 0.83 MAPT (0.49) MAPTHSD17B10ALDH1A1ERN1HIF1A
SCHEMBL2023572 0.79 MAPT (0.49) MAPTHSD17B10ALDH1A1ERN1HIF1A
SCHEMBL9654941 0.79 MAPT (0.47) MAPTHSD17B10ALDH1A1ERN1KDM4E
SCHEMBL9657636 0.78 AKR1B1 (0.45) HIF1AEPAS1ALOX15LMNAALOX12
SCHEMBL28417984 0.76 TUBB1 (0.63) MAPTHSD17B10ALDH1A1KDM4EALOX15
SCHEMBL6495895 0.76 BCHE (0.54) MAPTHSD17B10ALDH1A1KDM4ELMNA
SCHEMBL11064590 0.75 MAPT (0.50) MAPTHSD17B10ALDH1A1KDM4EALOX15
SCHEMBL9656536 0.75 HIF1A (0.46) MAPTHSD17B10ALDH1A1ERN1HIF1A
SCHEMBL9654846 0.74 CSNK2A2 (0.43) MAPTHSD17B10ALDH1A1KDM4EATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5134161-A Enzyme inhibitors for skin disorders, antiinflammatory agents SYNTEX (U.S.A.) INC. (US) 1992-07-28 — — US disclosed
US-4786652-A TOPICAL ADMINISTRATION SYNTEX (U.S.A.) INC. (US) 1988-11-22 — — US disclosed
EP-0282006-A1 Naphtalene anti-psoriatic agents SYNTEX (U.S.A.) INC. (US) 1988-09-14 — — EP disclosed
Send feedback